Nortran Pharmaceutical -NRT.V Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul S. who wrote (321)	3/30/1998 3:46:00 PM
From: Casey	of 1185

Paul: <<If Maedels specialty is the junior resource market, then I am not at all suprised that his stock picks have not performed. Show me a resource letter writer that has had success. >> Fwiw, Maedel's recommends a whole range of mini-cap stocks, including tech stocks and biotechs. He recommended IZP as a buy when it was above $3.00. His tech plays are particularly battered. What was unpleasant was when his plays did not pan out, he sidestepped the problem in his newsletter, or left it hanging. Faxes and emails to his service never yield an answer. I suggest you get a sample copy of his recent newsletter and take a look at his recommendation list. It's not pretty.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next